Valeant Pharmaceuticals vows to boost its $46-billion bid for Allergan

The heated takeover fight over Allergan Inc., the maker of Botox, continued Tuesday with the Canadian pharmaceutical company Valeant vowing to increase its $46-billion offer this month. Meanwhile, the Canadian firm's partner in the offer, activist investor Bill Ackman, wants Allergan Inc....